TF and asthma: To evaluate the therapeutic potential of targeting these asthma-related genes, a siRNA delivery system was developed and tested in a PCLS inflammation model by Kandil et al. This system comprised polyethyleneimine (PEI) as a polycationic carrier, transferrin (Tf) as a targeting ligand and melittin (Mel) as an endosomal escape agent.